T. Rowe Price Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-39,783
Closed -$1.68M 2920
2023
Q2
$1.68M Buy
39,783
+973
+3% +$41K ﹤0.01% 1550
2023
Q1
$1.38M Sell
38,810
-5,919
-13% -$211K ﹤0.01% 1625
2022
Q4
$1.64M Sell
44,729
-545
-1% -$20K ﹤0.01% 1541
2022
Q3
$2.14M Buy
45,274
+4,346
+11% +$205K ﹤0.01% 1429
2022
Q2
$2.93M Sell
40,928
-2,009
-5% -$144K ﹤0.01% 1510
2022
Q1
$3.48M Buy
42,937
+3,872
+10% +$313K ﹤0.01% 1536
2021
Q4
$4.01M Sell
39,065
-1,686
-4% -$173K ﹤0.01% 1527
2021
Q3
$3.57M Buy
40,751
+1,718
+4% +$150K ﹤0.01% 1559
2021
Q2
$3.49M Buy
39,033
+1,257
+3% +$112K ﹤0.01% 1578
2021
Q1
$2.87M Buy
37,776
+5,964
+19% +$452K ﹤0.01% 1593
2020
Q4
$2.17M Buy
31,812
+281
+0.9% +$19.1K ﹤0.01% 1609
2020
Q3
$1.68M Sell
31,531
-4,218
-12% -$224K ﹤0.01% 1600
2020
Q2
$2.08M Buy
35,749
+423
+1% +$24.6K ﹤0.01% 1525
2020
Q1
$1.39M Sell
35,326
-1,717
-5% -$67.7K ﹤0.01% 1599
2019
Q4
$2.2M Buy
37,043
+2,469
+7% +$147K ﹤0.01% 1574
2019
Q3
$1.84M Buy
34,574
+301
+0.9% +$16K ﹤0.01% 1592
2019
Q2
$1.75M Sell
34,273
-330,907
-91% -$16.9M ﹤0.01% 1627
2019
Q1
$18.9M Buy
365,180
+131
+0% +$6.78K ﹤0.01% 1190
2018
Q4
$14.4M Sell
365,049
-4,430
-1% -$174K ﹤0.01% 1239
2018
Q3
$19M Sell
369,479
-27,620
-7% -$1.42M ﹤0.01% 1246
2018
Q2
$18.6M Sell
397,099
-8,843
-2% -$415K ﹤0.01% 1225
2018
Q1
$14.4M Sell
405,942
-142,307
-26% -$5.05M ﹤0.01% 1274
2017
Q4
$23.9M Sell
548,249
-17,554
-3% -$765K ﹤0.01% 1116
2017
Q3
$29.6M Buy
565,803
+36,678
+7% +$1.92M 0.01% 1042
2017
Q2
$31M Buy
529,125
+47,089
+10% +$2.75M 0.01% 1009
2017
Q1
$22.1M Sell
482,036
-32,334
-6% -$1.48M ﹤0.01% 1119
2016
Q4
$27.1M Buy
514,370
+13,865
+3% +$729K 0.01% 1026
2016
Q3
$22.3M Buy
500,505
+146,735
+41% +$6.54M ﹤0.01% 1093
2016
Q2
$13.5M Buy
353,770
+2,695
+0.8% +$103K ﹤0.01% 1224
2016
Q1
$14.5M Buy
351,075
+139,845
+66% +$5.76M ﹤0.01% 1180
2015
Q4
$10.2M Buy
+211,230
New +$10.2M ﹤0.01% 1278